Form 4: Waters Corp SVP Jianqing Bennett Reports Acquisition and Disposal of Shares

Waters Corp SVP Jianqing Bennett reports the acquisition of performance shares and restricted stock, along with the granting of stock options.

Summary

• On February 5, 2025, Jianqing Bennett, SVP at Waters Corp, reported transactions involving the company's common stock and stock options.
• Mr. Bennett acquired 2,618 performance shares related to a performance stock unit award granted on February 25, 2022, which will service vest on March 1, 2025.
• He also acquired 615 shares of restricted stock that will vest 20% per annum starting February 5, 2026.
• Additionally, Mr. Bennett was granted stock options for 3,168 shares, vesting 20% per annum beginning February 5, 2026, and expiring on February 5, 2035.
• Following these transactions, Mr. Bennett beneficially owns 6,005 shares of common stock and 3,168 stock options.
• A Power of Attorney was executed in July 2024, authorizing Keeley Aleman, Christina Kelleher, Jodi Brueggeman, and Michael Lynn to act on Mr. Bennett's behalf for SEC filings.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and insider transactions, suggesting a stable and well-managed company. The sentiment is neutral to positive.

Positives

• The acquisition of performance shares indicates the achievement of performance goals set by the company.
• The granting of restricted stock and stock options aligns Mr. Bennett's interests with the long-term success of Waters Corp.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules for restricted stock and stock options suggest a continued relationship between Mr. Bennett and Waters Corp.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices, including performance-based equity and long-term incentives.

Comparison to Industry Standards

• Equity compensation, including stock options and restricted stock, is a common practice among publicly traded companies to align management's interests with those of shareholders.
• Vesting schedules, such as the 20% per annum vesting described in the document, are typical for these types of equity grants.
• Companies like Thermo Fisher Scientific and Agilent Technologies, which operate in similar industries, also utilize equity compensation as part of their executive compensation packages.

Stakeholder Impact

• The transactions reported may have a minor positive impact on shareholder sentiment, as they demonstrate management's alignment with the company's long-term performance.
• Employees may view the equity compensation as a positive sign of the company's commitment to its executives.

Key Dates